Latest ALRN reports update at 2024-05-15: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Aileron Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Aileron Therapeutics logo
Aileron Therapeutics ALRN
$ 2.95 -1.67%
mail-toReport an Error

Aileron Therapeutics EV/EBITDA Ratio 2011-2024 | ALRN

Annual EV/EBITDA Ratio Aileron Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.0369 -3.32 -0.41 -0.167 -2.49 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.0369 -3.32 -1.28